Screening for cardiovascular risk factors in adults with serious mental illness: A review of the evidence

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Baller, Julia B ^a   McGinty, Emma E ^a   Azrin, Susan T ^b   Juliano Bult, Denise ^b   Daumit, Gail L ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; DRUG USE; DYSLIPIDEMIA; GLUCOSE TOLERANCE TEST; HEALTH INSURANCE; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MEDICAID; MENTAL DISEASE; MOOD DISORDER; OBESITY; SCHIZOPHRENIA; SCREENING; SYSTEMATIC REVIEW; TOBACCO USE; TRIACYLGLYCEROL BLOOD LEVEL; VETERAN; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; DYSLIPIDEMIAS; EARLY DIAGNOSIS; FEMALE; MALE; MENTAL DISORDERS; PSYCHOLOGY; RISK FACTOR; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DYSLIPIDEMIAS; EARLY DIAGNOSIS; FEMALE; HUMANS; HYPERTENSION; MALE; MENTAL DISORDERS; OBESITY; RISK FACTORS; YOUNG ADULT;

EID: 84925834131     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0416-y     Document Type: Article

References (65)

1. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry. 1997;171:502-8.
2. Saha S, Chant D, McGrath J. A systematic review or mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;2007:1123-31.
3. Daumit GL, Anthony CB, Ford DE, Fahey M, Skinner EA, Lehman AF, et al. Pattern of mortality in a sample of maryland residents with severe mental illness. Psychiatry Res. 2010;176(2-3):242-5. doi: 10.1016/j.psychres.2009.01.006. Epub 2010 Mar 5.
4. Colton CP, Ronald W, Manderscheid P. Congruencies in increased mortality rates, years of life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(1):1-14.
5. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000;45:21-8.
6. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's general practice database. Arch Gen Psychiatry. 2007;64:242-9.
7. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298:1794-6.
8. Allison D, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a national institute of mental health meeting report. Am J Prev Med. 2009;2009(36):341-50.
9. McDevitt J, Snyder M, Miller A, Wilbur J. Perceptions of bariers and benefits to physical activity among outpatients in psychiatric rehabilitation. J Nurs Scholarsh. 2006;38(1):50-5.
10. Casagrande SS, Anderson CA, Appel L, Jerome G, Dickerson FB, Daumit GL. Dietary intake of adults with serious mental illness. Psychiatr Rehabil J. 2011;35(2):137-40.
11. Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illness: a preventive perspective. Harv Rev Psychiatry. 2006;14(4):212-22.
12. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999;1999(156):341-50.
13. United States Preventive Services Task Force (USPSTF): Reommendations for Adults. http://www.uspreventiveservicestaskforceorg/adultrechtm 2013.
14. American Diabetes Association. American psychiatric association, American association of clinical edocrinologists, North American association for the study of obesity: consensus development conference for antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601.
15. Kreyenbuhl J, Dickerson FB, Medoff DR, Brown CH, Goldberg RW, Fang L, et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis. 2006;194(6):404.
16. Sokal J, Messias E, Dickerson FB, Kreyenbuhl J, Brown CH, Goldberg RW, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421-7.
17. American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care. 2004;27 suppl 1:s11-4.
18. Butler M, Kane RL, McAlpine D, al; e: Integration of Mental Health/Substance Abuse and Primary Care. Prepared by the Minnesota Evidence-Based Practice Center under contract 290-02-0009. AHRQ pub no 09-E003. Rockville, MD, Agency for Healthcare Research and Quality, October 2008. Available at www.ahrq.gov/clinic/tp/mhsapctp.htm .
19. Ganguli R. Comorbidities of obesity in serious mental illness. Psychiatr Ann. 2011;41(10):469-72.
20. Miller BJ, Paschall CB, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv. 2006;57(10):1482-7.
21. Baillargeon JG, Paar DP, Wu H, Giordano TP, Murray O, Raimer BG, et al. Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2008;20(1):124-9.
22. Kilbourne AM, Lai Z, Bowersox N, Pirraglia P, Bauer MS. Does colocated care improve access to cardiometabolic screening for patients with serious mental illness? Gen Hosp Psychiatry. 2011;33(6):634-6.
23. Ma J, Xaio L, Stafford RS. Adult obesity and office-based quality of car ein the US. Obesity. 2009;17(5):1077-85.
24. National Ambulatory Medical Care Survey: National Ambulatory Medical Care Survey: 2010 Summary Tables. http://www.cdcgov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tablespdf 2010.
25. Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of medicaid claims data. J Clin Psychiatry. 2008;69(2):316-22.
26. Moeller KE, Rigler SK, Mayorga A, Nazir N, Shireman TI. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance. Schizophr Res. 2011;126(1-3):117-23.
27. Morrato EH, Newcomer JW, Kamat S, Baser O, Harnett J, Cuffel B. Metabolic screening after the American diabetes association's consensus statement on antipsychotic drugs and diabetes. Diabetes Care. 2009;32(6):1037-42.
28. Kilbourne AM, Greenwald DE, Hermann RC, Charns MP, McCarthy JF, Yano EM. Financial incentives and accountability for integrated medical care in department of veterans affairs mental health programs. Psychiatric services (Washington, DC). 2010;61(1):38-44.
29. Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc. 2010;85(1):27-35.
30. Kaplowitz RA, Scranton RE, Gagnon DR, Cantillon C, Cantillon C, Levenson JW, et al. Health care utilization and receipt of cholesterol testing by veterans with and those without mental illness. Gen Hosp Psychiatry. 2006;28(2):137-44.
31. Weissman EM, Zhu CW, Schooler NR, Goetz RR, Essock SM. Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics. J Clin Psychiatry. 2006;67(9):1323-6.
32. Barnett M, VonMuenster S, Wehring H, Popish S, McDonald K, Walker VM, et al. Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics. Ann Clin Psychiatry. 2010;22(1):9-18.
33. Pirraglia PA, Rowland E, Wu WC, Friedmann PD, O'Toole TP, Cohen LB, et al. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis. 2012;9:E51.
34. Kilbourne AM, Welsh D, McCarthy JF, Post EP, Blow FC. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med. 2008;23(10):1628-33.
35. Folsom DP, McCahill M, Bartels S, Lindamer LA, Ganiats TG, Jeste DV. Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatr Serv. 2002;53(11):1456-60.
36. Kuklina EV, Yoon PW, Keenan NL. Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999-2006. Ann Fam Med. 2010;8(4):327-33.
37. Behavioral Risk Factor Surveillance System: Cholesterol Awareness-2011 [ http://apps.nccd.cdc.gov/brfss/list.asp?cat=CA&yr=2011&qkey=8061&state=All ].
38. Dickerson FB, McNary W, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41:560-70.
39. National Ambulatory Medical Care Survey: 2010 Summary Tables [ http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf ].
40. National Hospital Ambulatory Medical Care Survey: 2010 Outpatient Department Summary Tables [ http://www.cdc.gov/nchs/data/ahcd/nhamcs_outpatient/2010_opd_web_tables.pdf ].
41. O'Callaghan C, Liew AYL, Yusof MSD, Duffy R, Breen EG, Kinsley B, et al. Screening for metabolic syndrome in long-term psychiatric illness: audit of patients receiving depot antipsychotic medication at a psychiatry clinic. The Eur J Psychol Psychiatry. 2011;25(4):213-22.
42. Barnes TR, Paton C, Hancock E, Cavanagh MR, Taylor D, Lelliott P, et al. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatrica Scandinavica. 2008;118(1):26-33.
43. Bobes J, Alegria AA, Saiz-Gonzalez MD, Barber I, Perez JL, Saiz-Ruiz J. Change in psychiatrists' attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. Eur Psychiatry. 2011;26(5):305-12.
44. Harrison MR, McMillan CF, Dickinson T. Service innovation: a comparison of two approaches for physical screening of psychiatric inpatients. Int J Psychiatry Clin Pract. 2012;16(2):157-60.
45. Wiechers IR, Viron M, Stoklosa J, Freudenreich O, Henderson DC, Weiss A. Impact of a metabolic screening bundle on rates of screening for metabolic syndrome in a psychiatry resident outpatient clinic. Acad Psychiatry. 2012;36(2):118-21.
46. Osborn DP, Nazareth I, Wright CA, King MB. Impact of a nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnessesPhase-two cluster randomised feasibility trial of community mental health teams. BMC Health Serv Res. 2010;10:61.
47. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, et al. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010;67(1):17-24.
48. Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, et al. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011;20(1):66-75.
49. Hodges B, Inch C, Silver I. Improving the psychiatric knowledge, skills, and attitudes of primary care physicians, 1950-2000: a review. Am J Psychiatr. 2001;158(10):1579-86.
50. Druss BG, Mauer BJ. Health care reform and care at the behavioral health-primary care interface. Psychiatr Serv. 2010;61:1087-92.
51. Michell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry. 2009;194:491-9.
52. Asch SM, McGlynn EA, Hogan MM, Hayward RA, Shekelle P, Rubenstein L, et al. Comparison of quality of care for patients in the veterans health administration and patients in a national sample. Ann Intern Med. 2004;141(12):938-45.
53. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the veterans affairs health care system on the quality of care. N Engl J Med. 2003;348(22):2218-27.
54. Kilbourne AM, Pirraglia PA, Lai Z, Bauer MS, Charns MP, Greenwald D, et al. Quality of general medical care among patients with serious mental illness: does colocation of services matter? Psychiatric services (Washington, DC). 2011;62(8):922-8.
55. Goodrich DE, Lai ZS, Lasky E, Burghardt AR, Kilbourne AM. Access to weight loss counseling services among patients with bipolar disorder. J Affect Disord. 2010;126(1-2):75-9.
56. Matthews AM, Huckans MS, Blackwell AD, Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord. 2008;10(2):266-70.
57. Kizer KW, Dudley RA. Extreme makeover: transformation of the veterans health care system. Annu Rev Public Health. 2009;30(1):313-39.
58. Hillestad R, Bigelow J, Bower A, Girosi F, Meili R, Scoville R, et al. Can electronic medical record systems transform health care? potential health benefits, savings. And Costs Health Affairs. 2005;24(5):1103-17.
59. Romano MJ, Stafford RS. Electronic health records and clinical decision support systems: impact on national ambulatory care quality. Arch Intern Med. 2011;171(10):897.
60. Reed M, Huang J, Brand R, Graetz I, Neugebauer R, Fireman B, et al. Implementation of an outpatient electronic health record and emergency department visits, hospitalizations, and office visits among patients with diabetes. JAMA. 2013;310(10):1060-5.
61. Jaspers MW, Smeulers M, Vermeulen H, Peute LW. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc. 2011;18(3):327-34.
62. Bao Y, Casalino LP, Pincus HA. Behavioral health and health care reform models: patient centered medical home, health home, and accountable care organization. J Behav Heal Serv Res. 2013;40:121-32.
63. (NCQA). NCfQA: HEDIS 2014. Healthcare Effectiveness Data and Information Set. In., vol. 1. Washington, DC: National Committee For Quality Assurance (NCQA); 2013.
64. Khaykin E, Eaton WW, Ford DE, Anthony CB, Daumit GL. Health insurance coverage among persons with schizophrenia in the United States. Psychiatric services (Washington, DC). 2010;61(8):830-4.
65. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283(19):2579-84.